Classification and Mechanisms of Action
Rational pharmacotherapy is based on understanding the sites of action of pharmacological agents. Physicians utilize drugs affecting voltage-gated Na⁺ and Ca²⁺ channels, as well as NMDA and GABA_A receptors.
A fundamental group for preventing the spread of pathological seizure discharges is voltage-gated sodium channel blockers located on neuronal membranes. Key representatives of this group include:
- Carbamazepine (Carbamazepinum);
- Phenytoin (Phenytoinum);
- Topiramate (Topiramatum).
It is important to note that topiramate has a mixed profile of activity, though Na⁺ channel blockade is one of its key components. When analyzing mechanisms of action, clear differential diagnosis is necessary. For example, when discussing sodium channels, phenobarbital (which acts as a GABA receptor agonist) or ethosuximide (which works via calcium channels) should be excluded.
Treatment of Absence Seizures
Absence seizures (petit mal) require a specific pharmacological approach. The indisputable drug of choice in this clinical situation is ethosuximide (Ethosuximidum).
The rationale for prescribing this agent lies in its unique mechanism: it selectively blocks T-type calcium channels localized in thalamic structures. This specific action is required to suppress absence seizures. Prescribing other popular agents, such as carbamazepine or phenytoin, for this seizure type is a critical error—they lack efficacy and can even worsen the patient's condition.
Management of Status Epilepticus
Status epilepticus represents a life-threatening medical emergency. Diazepam (Diazepamum) is used as the first-line agent for the emergency cessation of continuous seizures.
The choice of diazepam is dictated by clinical necessity: the fastest-acting drug possible is required. Typically administered intravenously, it causes potent enhancement of GABAergic inhibition in the brain. Phenobarbital and phenytoin may also appear in treatment protocols for status epilepticus, but their clinical role is different. These drugs are prescribed to prevent subsequent recurrence of seizure activity, but they are entirely unsuitable as starting agents for the emergency termination of an active seizure.